Search

everythinglearnresearchcommunity

for

Search:↓

The April 2014 issue of "Fertility and Sterility" discussed various reproductive health topics, including hormone therapy benefits, sperm and genetic factors in male infertility, and the link between PCOS and diabetes.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Early hair whitening may indicate a higher risk of heart disease in young and middle-aged men.

The review concludes that more research is needed to better improve the health outcomes for people with Polycystic Ovarian Syndrome.

The document concludes that careful history and physical exams are crucial for accurately diagnosing polycystic ovary syndrome and distinguishing it from other similar conditions.

Higher hs-CRP levels in Indian adolescent women with PCOS are more related to BMI than PCOS itself.

Children with classic congenital adrenal hyperplasia have thicker heart fat and more heart and blood vessel risk factors, especially if their condition is not well-controlled.

Severe vertex pattern hair loss may indicate a higher risk for artery plaque buildup.

Menopause significantly reduces skin collagen, leading to thinner, less elastic skin, and hormone replacement may help but requires careful consideration.

Early balding in young Indian men may indicate a higher risk of metabolic syndrome and potential heart disease.

Rosuvastatin improves lipid levels, reduces inflammation, but worsens insulin sensitivity in men with early-onset hair loss.

Excess male hormones in postmenopausal women can cause health issues and increase the risk of heart disease and diabetes; treatment depends on the cause.

Metformin and rosiglitazone improve blood vessel function in women with PCOS, with metformin also reducing insulin resistance and testosterone levels.

The free androgen index varies among women with different types of PCOS.

Hair loss can indicate brain aging and potential small vessel disease, but more research is needed to understand the clinical impact.

Common skin conditions can greatly affect a person's mental health and social life.

Medications for PCOS don't seem to raise heart disease risk.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

Women with irregular periods have a higher risk of heart disease.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Gray hair may be caused by lower antioxidant activity in hair cells.

Young adults with hair loss face higher risk of stiff arteries.

People with PCOS, especially if obese, often have NAFLD, linked to obesity, insulin resistance, and high androgen levels.

Women with severe types of PCOS are more likely to have metabolic syndrome, and belly fat is a key predictor of this risk.

Manage women's cholesterol with diet, exercise, and careful treatment choices, especially during pregnancy, PCOS, and menopause.

People with lichen planus are more likely to have dyslipidemia, especially higher triglyceride levels.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

The document concludes that accurate diagnosis and management of PCOS are crucial due to its associated health risks.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

The conclusion is that managing cholesterol is important for women, especially during pregnancy, breastfeeding, and with PCOS, and involves regular screening and careful treatment choices.